Celldex Therapeutics - 53 Year Dividend History | CLDX
Historical dividend payout and yield for Celldex Therapeutics (CLDX) since 1971. The current TTM dividend payout for Celldex Therapeutics (CLDX) as of November 29, 2024 is $0.00. The current dividend yield for Celldex Therapeutics as of November 29, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$1.820B |
$0.007B |
|
CELLDEX THERAPEUTICS is an integrated biopharmaceutical company that applies its comprehensive Precision Targeted Immunotherapy Platform to generate a pipeline of candidates to treat cancer and other difficult-to-treat diseases. Celldex's immunotherapy platform includes a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulators to create novel disease-specific drug candidates.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
